This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Alzinova Croissance future
Future contrôle des critères 0/6
Alzinova's revenue is forecast to decline at 61.7% per annum. EPS is expected to decline by 81.3% per annum.
Informations clés
n/a
Taux de croissance des bénéfices
-81.3%
Taux de croissance du BPA
| Biotechs croissance des bénéfices | 46.2% |
| Taux de croissance des recettes | -61.7% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 26 Jun 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | N/A | -84 | -84 | 1 |
| 12/31/2025 | N/A | N/A | -84 | -84 | 1 |
| 12/31/2024 | 52 | 82 | 4 | 11 | 2 |
| 3/31/2024 | 18 | -17 | -34 | -17 | N/A |
| 12/31/2023 | 20 | -16 | -35 | -15 | N/A |
| 9/30/2023 | 17 | -16 | -31 | -13 | N/A |
| 6/30/2023 | 17 | -16 | -32 | -15 | N/A |
| 3/31/2023 | 14 | -15 | -32 | -17 | N/A |
| 12/31/2022 | 17 | -13 | -27 | -10 | N/A |
| 9/30/2022 | 16 | -11 | -26 | -10 | N/A |
| 6/30/2022 | 15 | -9 | -27 | -12 | N/A |
| 3/31/2022 | 17 | -8 | -25 | -8 | N/A |
| 12/31/2021 | 17 | -8 | -27 | -10 | N/A |
| 9/30/2021 | 18 | -7 | -25 | -7 | N/A |
| 6/30/2021 | 19 | -7 | -24 | -5 | N/A |
| 3/31/2021 | 16 | -6 | -20 | -5 | N/A |
| 12/31/2020 | 15 | -6 | -21 | -6 | N/A |
| 9/30/2020 | 13 | -7 | -21 | -8 | N/A |
| 6/30/2020 | 12 | -6 | -18 | -7 | N/A |
| 3/31/2020 | 11 | -7 | -17 | -6 | N/A |
| 12/31/2019 | 7 | -6 | -11 | -4 | N/A |
| 9/30/2019 | 5 | -5 | -11 | -6 | N/A |
| 6/30/2019 | 6 | -5 | -11 | -5 | N/A |
| 3/31/2019 | 8 | -5 | -11 | -3 | N/A |
| 12/31/2018 | 9 | -4 | -13 | -4 | N/A |
| 9/30/2018 | 11 | -3 | -13 | -2 | N/A |
| 6/30/2018 | 10 | -3 | -11 | -2 | N/A |
| 3/31/2018 | 8 | -2 | -9 | -2 | N/A |
| 12/31/2017 | 6 | -3 | N/A | -2 | N/A |
| 9/30/2017 | 5 | -3 | N/A | -2 | N/A |
| 6/30/2017 | 4 | -3 | N/A | -3 | N/A |
| 3/31/2017 | 5 | -4 | N/A | -3 | N/A |
| 12/31/2016 | 5 | -3 | N/A | -3 | N/A |
| 9/30/2016 | 5 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 4 | -4 | N/A | -3 | N/A |
| 3/31/2016 | 2 | -3 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -3 | N/A | -3 | N/A |
| 12/31/2014 | 1 | 0 | N/A | -1 | N/A |
| 12/31/2013 | 1 | 0 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if ALZ BTA's forecast earnings growth is above the savings rate (1%).
Bénéfices vs marché: Insufficient data to determine if ALZ BTA's earnings are forecast to grow faster than the Swedish market
Croissance élevée des bénéfices: Insufficient data to determine if ALZ BTA's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: ALZ BTA's revenue is expected to decline over the next 3 years (-61.7% per year).
Croissance élevée des revenus: ALZ BTA's revenue is forecast to decline over the next 3 years (-61.7% per year).
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if ALZ BTA's Return on Equity is forecast to be high in 3 years time